ArticleEClinicalMedicine2023

Corrigendum to "Treatment-related adverse events associated with HER2-Targeted antibody-drug conjugates in clinical trials: a systematic review and meta-analysis" [EClinicalMedicine 55 (2022) 101795].

Zhiwen Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.